Lateral flow assays for non-diagnostic analytes

Abstract

Methods of determining whether a non-diagnostic analyte is present in a non-diagnostic sample are provided. Aspects of the methods include applying a non-diagnostic sample to a sample receiving region of a lateral flow assay device and reading a detection region to determine whether a non-diagnostic analyte is present in the non-diagnostic sample. Also provided are kits that find use in practicing methods of the invention.

1 - 41 . (canceled) 
     
     
         42 . A kit comprising:
 a lateral flow assay device comprising a sample receiving region and a detection region downstream from the sample receiving region, wherein the detection region comprises a capture binding member that specifically binds to a non-diagnostic analyte; and   a control for the non-diagnostic analyte.   
     
     
         43 . The kit according to  claim 42 , wherein the capture binding member is selected from the group consisting of: an antibody, a protein, a peptide, a nucleic acid and a hapten. 
     
     
         44 . The kit according to  claim 43 , wherein the capture binding member is an antibody. 
     
     
         45 . The kit according to  claim 43 , wherein the capture binding member is a protein. 
     
     
         46 . The kit according to  claim 43 , wherein the capture binding member is a peptide. 
     
     
         47 . The kit according to  claim 43 , wherein the capture binding member is a nucleic acid. 
     
     
         48 . The kit according to  claim 43 , wherein the capture binding member is a hapten. 
     
     
         49 . The kit according to  claim 42 , wherein lateral flow assay device further comprises an internal control region downstream from the detection region. 
     
     
         50 . The kit according to  claim 42 , wherein the internal control region comprises a specific binding member that specifically binds to an internal control. 
     
     
         51 . The kit according to  claim 50 , wherein the lateral flow assay device comprises an internal control positioned between the sample receiving region and the internal control region. 
     
     
         52 . The kit according to  claim 50 , wherein the kit comprises an amount of an internal control that is separate from the lateral flow assay device. 
     
     
         53 . The kit according to  claim 42 , wherein the lateral flow assay device comprises a reporter binding member positioned between the sample receiving region and the detection region. 
     
     
         54 . The kit according to  claim 42 , wherein the detection region of the lateral flow assay device comprises two or more distinct capture probe regions. 
     
     
         55 . The kit according to  claim 42 , wherein the lateral flow assay device comprises a single sample receiving region and a detection region comprising capture probes for each of two or more non-diagnostic analytes. 
     
     
         56 . The kit according to  claim 42 , wherein the lateral flow assay device comprises two or more lanes each comprising a separate sample receiving region and detection region. 
     
     
         57 . The kit according to  claim 56 , wherein the detection region of each lane detects the same non-diagnostic analyte. 
     
     
         58 . The kit according to  claim 56 , wherein the detection region of each lane detects a different non-diagnostic analyte. 
     
     
         59 . The kit according to  claim 42 , wherein the kit further comprises a sample applicator configured to apply the non-diagnostic sample to the sample receiving region of the lateral flow assay device. 
     
     
         60 . The kit according to  claim 42 , wherein the capture binding member specifically binds to a recombinant virus. 
     
     
         61 . The kit according to  claim 60 , wherein the recombinant virus is selected from the group consisting of: a retrovirus, a baculovirus, and an adenovirus.